Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co., Ltd., commonly referred to as AmoyDx, is a leading biotechnology company headquartered in China. Established in 2008, the company has made significant strides in the field of molecular diagnostics, focusing on oncology and infectious diseases. With a strong presence in Asia and expanding operations globally, AmoyDx is renowned for its innovative diagnostic solutions. The company offers a range of core products, including advanced PCR-based assays and next-generation sequencing (NGS) technologies, which are distinguished by their high sensitivity and specificity. AmoyDx has achieved notable recognition in the industry, positioning itself as a trusted partner for healthcare providers and researchers alike. With a commitment to enhancing patient outcomes, AmoyDx continues to drive advancements in precision medicine and diagnostics.
DitchCarbon Score
How does Amoy Diagnostics Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Amoy Diagnostics Co., Ltd.'s score of 15 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Amoy Diagnostics Co., Ltd.'s reported carbon emissions
Amoy Diagnostics Co., Ltd., headquartered in China, currently does not report specific carbon emissions data, as no figures are available. However, the company has made significant commitments towards climate action. As of October 2023, Amoy Diagnostics is classified as "Committed" to near-term reduction targets, indicating a proactive approach to addressing its carbon footprint. While specific reduction targets have not been disclosed, the company's commitment to sustainability aligns with industry standards in the healthcare sector, which is increasingly focused on reducing greenhouse gas emissions. Amoy Diagnostics has not yet committed to a net-zero target, but its ongoing initiatives reflect a dedication to improving environmental performance. In summary, while detailed emissions data is lacking, Amoy Diagnostics Co., Ltd. is actively engaged in climate commitments, demonstrating a forward-thinking approach in the healthcare technology sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Amoy Diagnostics Co., Ltd. is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
